Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
Status:
Withdrawn
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study, a nonrandomized open-label safety and exploratory study, will evaluate the safety
of topical norepinephrine in post-surgical breast cancer patients who are undergoing
radiation therapy.
The study will also provide information about whether topical norepinephrine can prevent or
decrease the severity of the radiation dermatitis experienced by these patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ProCertus BioPharm, Inc
Collaborator:
H. Lee Moffitt Cancer Center and Research Institute